Elena S Ratner MD
Gynecologic Oncology
Associate Professor, co-Division Director, Gynecologic Oncology,Yale University School of Medicine
Join to View Full Profile
800 Howard AveYale Physicians Bldg 3RD FLRNew Haven, CT 06519
Phone+1 203-785-4176
Fax+1 203-785-5886
Dr. Ratner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Elena Ratner is an obstetrician/gynecologist in New Haven, CT and is affiliated with multiple hospitals in the area, including Yale-New Haven Hospital and Lawrence + Memorial Hospital. She received her medical degree from University at Buffalo, School of Medicine and Biomedical Sciences and has been in practice 14 years. She specializes in gynecologic oncology and is experienced in general obstetrics and gynecology and gynecologic oncology.
Education & Training
Yale-New Haven Medical CenterFellowship, Gynecologic Oncology, 2007 - 2010- Yale-New Haven Medical CenterResidency, Obstetrics and Gynecology, 2003 - 2007
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2003
Certifications & Licensure
CT State Medical License 2007 - 2026
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
Publications & Presentations
PubMed
- 1 citationsTargetable ERBB2/HER2 Mutations in Gynecologic Malignancies: Clinicopathological, Immunohistochemical, and Molecular Correlations.Padmini A Manrai, Austin McHenry, Tong Sun, Alessandro D Santin, Elena Ratner
International Journal of Gynecological Pathology. 2025-03-01 - Exercise and Nutrition to Improve Cancer Treatment-Related Outcomes (ENICTO).Kathryn H Schmitz, Justin C Brown, Melinda L Irwin, Kim Robien, Jessica M Scott
Journal of the National Cancer Institute. 2025-01-01 - 1 citationsUterine teratoma and the role of short-tandem repeat genotyping in understanding origins.Abdelrahman AlAshqar, Vijaya Kadam Maruthi, Rita Abi-Raad, Michelle Greenman, Pei Hui
Gynecologic Oncology Reports. 2024-12-01
Journal Articles
- Phase II Evaluation of Nivolumab in the Treatment of Persistent or Recurrent Cervical Cancer (NCT02257528/NRG-GY002)Alessandro D Santin, Michael Frumovitz, Natalia Buza, Samir Khleif, Elena S Ratner, Roisin E O'Cearbhaill, Michael Birrer, Gynecologic Oncology
Press Mentions
Cancer Warning Signs for Women from Yale's Dr. Elena RatnerMarch 17th, 2025- Does Taking ‘The Pill’ Reduce Ovarian Cancer Risk?February 21st, 2025
- Cancer Remission like Catherine’s Does Not Always Mean the Illness Is CuredJanuary 15th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
